Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)
Clinical trial NCT04371666 · TERMINATED
Trial details
- NCT number
- NCT04371666
- Sponsor
- Kyntra Bio
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2023-02-13
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.